Participated · Series A · Jul 2023

TolerogenixX develops personalized cell therapies aimed at inducing donor-specific immune tolerance to prevent organ rejection and treat autoimmune diseases. Its lead product, MIC-Lx, is made from donor peripheral blood mononuclear cells modified by the company's proprietary MIC technology and administered intravenously prior to transplantation. MIC production is fast (manufacturable within 24 hours), scalable and uses leukapheresis-harvested donor cells. Five-year Phase I follow-up data show durable donor-specific immunosuppression, increased regulatory B lymphocytes, stable renal graft function, no donor-specific HLA antibodies or acute rejections, and fewer opportunistic infections versus matched controls. The company has expanded its Phase IIb TOL2 study to include an arm B that tests minimal immunosuppression and weaning off certain drugs. Preclinical data also indicate potential application in autoimmune diseases, and the company is pursuing completion of its Phase II program. TolerogenixX is privately held, was founded in 2016 and is based in Heidelberg, Germany; it recently completed a second Series A closing that increased its funding. TolerogenixX GmbH is a Heidelberg-based developer of a patented and clinically tested cell therapy technique for individualized immunosuppression in transplant patients. The company’s process treats patients' white blood cells to induce targeted disabling of undesired immune reactions. In a Phase I clinical trial applied during kidney transplants, treated patients became tolerant of the donated organ. TolerogenixX was founded at Heidelberg University Hospital and is led by CEO Dr. Matthias Schaier. The company plans to pursue further applications in transplantation of other organs and in the causal treatment of autoimmune diseases. It raised seed funding from High‑Tech Gründerfonds and intends to use the proceeds to finance preparations for a Phase II clinical trial beginning in spring 2018.

Led · Seed · Jul 2022

TFK operates a curated omnichannel marketplace offering shoes, beauty, personal care, accessories and home fashion items, with features like a virtual fitting room and outfit recommendations. The platform positions itself as a digital partner to brands, providing operations, fulfillment, co-marketing and digital content creation services. It monetizes via product mark-ups, consignment commissions, and fees for ancillary services such as photography and marketing. The marketplace hosts over 200 brands and serves more than 150,000 customers, with roughly 40% of monthly sales from returning customers and brands growing 10–15% month-over-month. Total sales volume grew threefold from April 2021 to April 2022. The company plans to use funding to scale technology, expand the team, and optimize operations and end-customer experience; its workforce is 43% female and 50% of managers are women.

Participated · Equity · May 2020

Countingup provides a business current account combined with automated bookkeeping and accounting tools aimed at micro and small businesses. Its product includes a bank account with its own sort code and account number, a Mastercard, faster payments, direct debits, automated bookkeeping, invoicing, receipts capture, bill payments, tax estimates and profit-and-loss reporting. Accountants can be granted limited web access to view clients' real-time bookkeeping data. The company says it serves over 34,000 business customers and combines SaaS subscription revenue with fintech income such as interchange on card spend. Countingup’s long-term vision is to be the single financial hub for micro businesses in the U.K. and beyond; planned product work includes tax filing, new financial services (loans, card payment services), multi-currency invoicing and payments and a web version of the app. The startup is scaling its team from 30 to 80 people to accelerate its roadmap and build out sales and marketing for growth. Countingup operates a business current account that combines banking with bookkeeping to automate accounting for sole traders and small businesses. Users can open a Countingup business current account on their smartphone in under five minutes and access typical banking and accounting features. The company recently launched an Accountant Hub, a web-based system for accountants to manage and collaborate with SME clients. Countingup was founded by Tim Fouracre, who previously founded cloud accounting software Clear Books, and now serves about 20,000 business customers. It aims to become the financial hub for roughly 1 million UK micro-businesses and sees HMRC’s Making Tax Digital as increasing demand for its product. Countingup recently raised a £4 million bridge round to accelerate its banking and accounting roadmap. Countingup provides a business current account that merges banking and bookkeeping into a single smartphone app. Users can open an account via the iOS or Android app in a claimed five minutes and receive a U.K. sort code/account number and a contactless Mastercard. The app currently includes profit and loss reporting, bookkeeping categorisation and the ability to attach receipts to transactions. Invoicing is slated to launch later this year, and the 2018 roadmap lists automated receipt scanning plus tax calculations and filing. Founded last year by Tim Fouracre, Countingup aims to be the financial platform for 1 million U.K. small businesses and already has about 4,000 customers. The company is signing up roughly 1,500 businesses per month. Countingup is building a smartphone app that combines a business bank account with automated bookkeeping and accounting tools targeted at sole traders. Users can open a UK current account in about five minutes and receive a UK sort code/account number plus a contactless Mastercard. The app will automate reconciliation of expenses, submit VAT returns, generate profit-and-loss reports and create invoices. The company aims to simplify bookkeeping for the UK’s roughly 4.2 million sole traders. Countingup plans to launch its banking account in the U.K. later this year, with the integrated accounting functionality following early next year. The startup was founded by Tim Fouracre, the founder of Clear Books, and has raised initial capital to fund the product rollout.

Led · Series A · Nov 2019

Yodawy develops a healthcare platform focused on prescription fulfillment and delivery to address major issues in Egypt’s healthcare system. The company partners with insurance companies and healthcare service providers to enhance patient access and experience. Yodawy serves about 35 health insurance and healthcare service providers and has contracts with over 800 businesses, 20 hospitals, and 30 clinics. It works with roughly 3,000 pharmacies across Egypt and has fulfilled over 6 million prescriptions since founding. The company plans to use new funding to grow its customer base and expand technology-enabled prescription fulfillment services to add value to the healthcare services industry. Yodawy operates a technology platform that digitizes the end-to-end prescription cycle, including an e-prescription gateway for doctors, an approvals engine for insurers and an e-pharmacy fulfillment offering. The company serves roughly 300 corporate clients, partners with 20 health insurers and 500 doctors, and works with a network of about 3,000 pharmacies. Its platform processes almost 200,000 prescriptions monthly across 30 cities and has handled over 4 million prescriptions through corporate programs; its e-prescription gateway generates more than 2,000 e-prescriptions daily. Yodawy reports serving more than 50,000 recurring chronic patients monthly and says revenue has grown 400% since its last priced round 18 months ago. The startup runs a Care Program that provides monthly medication refills and processes daily deliveries across 38 Egyptian cities. It plans to use new capital to expand across Middle East and Africa, scale prescription processing, automate operations further and bolster tech-enabled fulfillment capabilities. Yodawy is a Cairo-based medicine delivery and digital claims startup operating iOS and Android apps that let users browse and order medicines and personal-care products from nearby pharmacies. The app supports medical insurance co-payment plans and claims processing. The company partners with more than 2,500 pharmacies across 30 cities in Egypt. Yodawy positions itself as a pharmacy benefits and claims-processing solution for consumers, pharmacies and insurers. It won the Sanofi pitch competition at VivaTechnology 2019, and investors have praised its vision and go-to-market progress. The article does not disclose revenues, users, or specific plans for the new funding.